Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Martin Cannon

Concepts (295)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

The timeline below shows the dates (blue tick marks) of publications associated with Martin Cannon's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Martin Cannon has written about over time.
DNA-Binding Proteins, 5 publications between 2002 and 2007, average publication date June 2005. Uterine Cervical Neoplasms, 13 publications between 2002 and 2011, average publication date June 2005. Oncogene Proteins, Viral, 7 publications between 2002 and 2011, average publication date June 2006. Antibodies, Monoclonal, 5 publications between 2002 and 2019, average publication date October 2007. T-Lymphocytes, Cytotoxic, 12 publications between 2003 and 2013, average publication date November 2007. CD8-Positive T-Lymphocytes, 11 publications between 2002 and 2023, average publication date November 2008. Antigens, Neoplasm, 11 publications between 2002 and 2019, average publication date December 2008. Dendritic Cells, 26 publications between 2002 and 2023, average publication date January 2009. Immunotherapy, 12 publications between 2002 and 2019, average publication date February 2009. CD4-Positive T-Lymphocytes, 8 publications between 2002 and 2023, average publication date April 2009. Lymphocytes, Tumor-Infiltrating, 4 publications between 2003 and 2019, average publication date June 2009. Neoplasm Recurrence, Local, 3 publications between 2004 and 2020, average publication date May 2010. Ovarian Neoplasms, 23 publications between 2002 and 2023, average publication date July 2010. T-Lymphocytes, Regulatory, 6 publications between 2009 and 2011, average publication date November 2010. Cancer Vaccines, 13 publications between 2005 and 2020, average publication date January 2011. Indoleamine-Pyrrole 2,3,-Dioxygenase, 3 publications between 2011 and 2014, average publication date December 2012. Neoplasms, 4 publications between 2007 and 2019, average publication date April 2013. p38 Mitogen-Activated Protein Kinases, 2 publications between 2013 and 2014, average publication date August 2013. Th17 Cells, 3 publications between 2011 and 2020, average publication date February 2015. Interleukin-17, 2 publications between 2011 and 2020, average publication date December 2015.

To see the data from this visualization as text, click here.
Cannon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description